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Abstract Hyperphosphorylated tau has long been pro-
posed as the key molecule disrupting normal neuronal
microtubule dynamics and leading to neuroWbrillary degen-
eration in Alzheimer disease. Here we provide a direct
evidence of hyperphosphorylated tau-induced disruption of
microtubule network. Using Nocodozole-treated and deter-
gent-extracted cells, we created a neuronal environment in
mouse embryonic Wbroblasts, 3T3 cells, by replacing their
cytoplasm with adult rat brain cytosol. By recreating neuro-
nal microtubule network in these cells, we were able to fol-
low the eVects of hyperphosphorylated tau on microtubule
dynamics in real time. Whereas recombinant human brain
tau promoted assembly and bundling of microtubules,
abnormally hyperphosphorylated tau isolated from Alzhei-
mer disease brain cytosol (AD P-tau) inhibited the assem-
bly and disrupted preformed microtubule network by
sequestering normal brain tau and MAP2. This breakdown
of the microtubule network was reversed by treatment of
the extracted cells with protein phosphatase-2A. This study,
for the Wrst time, provides direct mechanistic insights into
the molecular basis of both axonal and dendritic neurode-
generation seen in Alzheimer disease.
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Introduction
Alzheimer’s disease (AD) is characterized by profound
central neurodegeneration. While it is a recurring theme in
many neurological and neuro-psychiatric disorders, the pre-
cise mechanisms leading to the loss of neuronal mass have
varying etiologies. In neuroWbrillary degeneration of Alz-
heimer type, the aVected neurons exhibit a particular type
of pathology that evolves in a distal-to-proximal manner.
This so-called, retrograde degeneration begins distally in
the axo-dendritic network disrupting normal synaptic activ-
ity. The basis for retrograde degeneration can be explained
by the presence of altered microtubule (MT) dynamics.
MTs play an essential role in maintaining the structural
and physiological integrity of neurons. Neurodegenerative
disorders, including AD, show evidence of cytoskeletal
dysfunction at both cytoarchitectural and molecular levels.
Changes in neuronal shape, loss of dendrites and dendritic
spines and abnormal accumulation of cytoskeletal proteins
either in the form of inclusions like neuroWbrillary tangles
of paired helical Wlaments (PHF) seen in AD [24], or Lewy
bodies seen in Parkinson’s disease [29], constitute evidence
of cytoarchitectural abnormalities. These neurons with ana-
tomical aberrations show impaired function, which is seen
as loss of synapses, decrease in synaptic conductivity and
synaptic plasticity. This places the neuronal cytoskeleton as
a key target for research and drug development.
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number of microtubule-associated proteins (MAP), the
high molecular weight MAP1 and MAP2, as well as the
50–75 kDa tau proteins [37, 39]. It was previously
reported by us that in AD, tau is abnormally hyperphosph-
orylated and aggregated into bundles of paired helical Wla-
ments (PHFs), which progressively replace the neuronal
cytoskeleton [20, 21]. In situ and in vitro observations sug-
gest that the cytosolic/non-Wbrillized abnormally hyper-
phosphorylated tau is inhibitory to MT assembly and
stability [1, 2, 3, 25, 31], whereas Wbrillized tau is not [5,
9]. Moreover, only hyperphosphorylated tau, and neither
MAP1 nor MAP2, has been shown to accumulate in the
aVected neurons in AD and related tauopathies. While it is
desirable to study the eVects of tau hyperphosphorylation
on MT function in an in vivo system, there are several lim-
itations surrounding direct and isolated manipulation of
tau phosphorylation and its eVect on MT dynamics in the
living cell. Both genetic and pharmacologic means of
studying mechanisms of neuroWbrillary degeneration have
several pitfalls. Transfected cell lines and transgenic ani-
mals overexpressing wild type, pseudophosphorylated or
mutated tau do not reXect the pathology in AD in which
neither any causative tau gene mutation nor increase in tau
messenger RNA has been found [15, 32]. Modifying
kinase and phosphatase levels/activities in the cell to
achieve tau hyperphosphorylation [13] aVects several other
pathways in the cell [6, 10, 12, 14, 23, 40] and may not
truly reXect the disease state. Consequently, the mecha-
nisms proposed for the apparent toxicity of hyperphosph-
orylated tau have not yet been identiWed in the cell and
therefore remain unestablished.
Detergent extraction of cells has been extensively
employed in the literature to study components of the cyto-
skeleton [7]. When cells are treated with a non-ionic deter-
gent, such as Triton X-100, approximately 70% of the
cytosolic proteins are extracted [30]. Such detergent-
extracted cells retain many of the morphological features of
the cytoskeleton seen in intact cells, including microWla-
ments, microtubules, intermediate Wlaments and associated
proteins [16, 35].
Here, we describe a model in which we disrupted the
MT network of 3T3 cells (mouse embryonic Wbroblasts)
with Nocodazole (Noco), followed by removal of the cyto-
plasm by extraction with Triton X-100 (Tri), and replaced
the MT network of the host cells (Noco/Tri cells) with that
polymerized from adult rat brain cytosol. The MT network
formed from rat brain tubulin, MAP2 and tau created a neu-
ron-like environment in which we could directly study the
eVects of AD P-tau in real time. We found that AD P-tau
causes breakdown of MT network by sequestering both tau
and MAP2. A compromised MT network both in the axons
and dendrites might be the basis of the progressive retrograde




The following primary antibodies were used: DM1A,
(1:2000; Sigma, St Louis, MO, USA), a mouse monoclonal
antibody to  tubulin; YL1/2, (Harlan Sera-Lab, Leicester-
shire, UK), a rat monoclonal antibody to tyrosinated/
dynamic-tubulin ; anti- Glu-tubulin, (1:500, a gift from A
del C. Alonso), a rabbit polyclonal antibody to detyrosi-
nated tubulin; 134d, (1:1000 for immunocytochemistry,
1:5000 for Western blots), a rabbit polyclonal antibody to
total tau [11]; SMI52, (1:200; Sternberger Monoclonals,
MD, USA), a mouse monoclonal antibody to MAP2; Tau-
1, (1:100, a gift from L. Binder), a mouse monoclonal anti-
body to un-phosphorylated tau; pSer 422, (1:100, raised in
our laboratory), a rabbit polyclonal antibody to phosphory-
lated tau at serine 422; PHF-1, (1:5000, a gift from P.
Davies), a mouse monoclonal antibody to phosphorylated
tau at serine 396 and serine 404; M4, (1:2000, a gift from
Y. Ihara), a mouse monoclonal antibody to phosphorylated
tau at threonine 231 and serine 235; 12E8, (1:2000, a gift
from D. Schenk), a mouse monoclonal antibody to phos-
phorylated tau at serine 262 and serine 356. The following
secondary antibodies were used: Alexa 488-conjugated
goat anti-mouse IgG antibody and Alexa 594-conjugated
goat anti-rabbit or anti-rat IgG antibody (Molecular probes,
Carlsbad, CA, USA); horseradish peroxidase-conjugated
anti-mouse (Jackson ImmunoResearch, West Grove, PA,
USA).
Preparation of rat brain cytosol
Adult Wistar rats (Charles River Laboratories, Wilmington,
MA, USA), 3–5 months old, were used to prepare 61,000 g
brain cytosolic extract as described previously [4]. BrieXy,
the brain was homogenized in equal volume (w/v) of chilled
PEM buVer (100 mM PIPES, 1 mM EGTA, 2 mM MgCl2
at pH 6.9), containing a cocktail of protease inhibitors
(4 g/ml Aprotinine, 4 g/ml Leupeptin, and 1 g/ml Pep-
statin). The homogenate was centrifuged at 61,000g at 4°C
for 30 min and the supernatant was referred as the cytosol.
Preparation of Noco/Tri 3T3 cells
Mouse embryonic Wbroblast (3T3) cells were plated
on poly-D-lysine coated 8-well culture slides (BD Bio-
sciences, Bedford, MA, USA) and cultured in DMEM
supplemented with 10% neonatal calf serum (both from123
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ence, the cells were washed in PEM buVer and either
extracted with 0.2% Triton X-100 for 1 min at 37°C or pre-
treated with 10 M nocodazole (ICN Pharmaceuticals,
Casta Mesa, CA, USA) at 37°C for 4 h to depolymerize
endogenous MTs before detergent extraction. The extracted
cells, thus obtained were referred to as Noco/Tri cells.
Isolation of recombinant normal human tau and AD P-tau
Recombinant human brain tau410 was expressed in the pro-
karyotic expression vector pRK172 and was puriWed as
described previously [36], except that the perchloric acid
extraction was avoided. AD P-tau was isolated from frozen
autopsied AD brains, obtained within 6 h postmortem, as
described [26] and further puriWed by Sepharose G-column
chromatography (Amersham Bioscience, Arlington Heights,
IL, USA).
Microtubule Assembly in Noco/Tri cells
Noco/Tri cells were rinsed with PEM buVer, and incubated
with rat brain cytosol in the presence of 1 mM GTP at 37°C
to study microtubule dynamics. Where indicated, recombi-
nant tau410or AD P-tau (100 g/ml) was added and the
extracted cells were analyzed for MT assembly by immu-
nocytochemistry.
Dephosphorylation of AD P-tau by protein phosphatase-2A
Dephosphorylation of AD P-tau was carried out as
described previously [19, 38]. BrieXy, AD P-tau (0.2 mg/
ml) was incubated in a mixture of 50 mM Tris, pH 7.0,
20 mM -mercaptoethanol, 0.1 mg/ml bovine serum albu-
min, 1.0 mM MnCl2, 10 g/ml each of leupeptin, pepstatin
and aprotinin, and 1.0 U/ml protein phosphatase-2A at
37°C for 45 min. Protein phosphatase-2A holoenzyme was
puriWed from bovine brain as described previously [38]. For
Western blot analysis, the reaction was stopped by the addi-
tion of 2 £ SDS-PAGE sample buVer and subjected to
SDS-polyacrylamide gel electrophoresis. The blots were
developed with the primary antibodies 134d, Tau-1, PHF-1,
M4 and 12E8, followed by incubation with anti-mouse IgG
conjugated with horseradish peroxidase and ECL detection
reagents (Amersham Biosciences Corp., Piscataway, NJ).
Immunocytochemistry
After treatment, the extracted cells were Wxed in a mixture
of 0.3% glutaraldehyde and 0.5% NP-40 in PEM buVer at
37°C for 10 min, washed with PBS and treated with 10 mg/
ml sodium borohydride (Sigma-Aldrich, St Louis, MO) for
7 min. The extracted cells were then incubated with 0.1 M
glycine in PBS for 20 min, washed with PBS and blocked
with 4% horse serum for 1 h at 37°C. The cells were incu-
bated with the appropriate primary antibodies overnight at
4°C. Next morning, after extensive washing with PBS, the
cells were incubated in the blocking solution for 30 min at
room temperature and then incubated with Alexa 488-con-
jugated anti-mouse antibody and Alexa 594-conjugated
anti-rabbit or anti-rat antibody simultaneously, each at a
Wnal dilution of 1:1000, for 1 h at room temperature.
Images were captured with Nikon PCM 2000 Confocal
Imaging System.
Analysis of microtubule assembly by Western blot
Rat brain cytosol (15%) was incubated in 100 l of PEM
buVer containing 1 mM GTP at 37°C for 1 h in the presence
or absence of normal or AD P-tau. The reaction mixture
was then centrifuged at 5,600g, at 37°C for 10 min to sepa-
rate assembled MTs. The supernatant and the MT pellets
were then lysed in 1% sodium dodecyl sulfate (SDS) and 1%
-mercaptoethanol, followed by bath sonication and
boiling for 5 min. Indicated volumes of supernatant and
dissolved pellets were subjected to SDS-polyacrylamide
gel electrophoresis and employed for Western blots on
PVDF membranes as described previously [20]. The blots
were developed with the primary antibody anti- tubulin
(DM1A), followed by incubation with anti-mouse IgG con-
jugated with horseradish peroxidase and ECL detection
reagents (Amersham Biosciences Corp., Piscataway, NJ).
Results
MT assembly in Noco/Tri cells
We employed 3T3 cells to study microtubule network
assembly in intact cells and after extraction with Triton
X-100. Compared to the intact cells (Fig. 1a–c), Triton-
extracted cells displayed remarkable preservation of the
microtubule network (Fig. 1d). As previously reported [8],
the MT in intact cells mainly contained tyrosinated (Tyr)
tubulin, a form of tubulin found predominantly in dynamic
assemblies of MT. We used detergent extraction in Noco-
dazole treated 3T3 cells to obtain a relevant “platform” on
which to study MT dynamics in the cellular context. After
extraction with Triton X-100, majority of the unpolymer-
ized tubulin was removed, while some free tubulin could be
seen attached to the detergent-resistant platform of the
Noco/Tri cells (Fig. 1f). Next, rat-brain cytosol was used as
a source of tubulin to form MT on Noco/Tri cells (Fig. 1g–
k). Only minimal MT assembly was observed at concentra-
tions of 5–10% cytosol (Fig. 1g, h), whereas MTs readily
assembled in the presence of higher concentrations of the123
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Nocodazole treatment inhibited MT assembly in Noco/Tri
cells and free tubulin could be seen attached to the Noco/
Tri cells (Fig. 1l).
To investigate the dynamic course of MTs in Noco/Tri
3T3 cells, the time course of MT assembly was studied at
diVerent time intervals (from 1 min to 4 h) after incubation
of the extracted cells with 25% rat brain cytosol in the pres-
ence of 1 mM GTP at 37°C. Microtubule-organizing center
(MTOC)-like structures were evident as early as 1 min post
incubation. Assembled MTs were observed growing from
MTOC-like structures by 10 min and were stable up to 4 h
(Fig. 2a).
To study the time course of MT disassembly, MTs were
Wrst assembled in Noco/Tri cells in the presence of 25% rat
brain extract containing 1 mM GTP for 20 min. The
extracted cells were then washed and incubated in PEM
buVer, and Wxed at diVerent time intervals to study the time
course of disassembly. Almost all MTs depolymerized by
1 h in this experimental paradigm (Fig. 2b).
Tubulin undergoes a unique post-translational modiWca-
tion in which a tyrosine is either attached to its C-terminal
(glutamate) by a speciWc tubulin tyrosine ligase or is removed
by tubulin carboxypeptidase. The generation of Glu-tubulin
is a post-polymerization event in which detyrosination
of some Tyr-MT forms Glu-MT as early as 20–25 min of
polymerization. Consequently, Glu-tubulin predominates in
stable assemblies of MTs present in diVerentiated cells
such as neurons [22]. More than 75% of  tubulin in the
adult mammalian brain is believed to be Glu-tubulin [33].
We found that Glu-tubulin represented the major tubulin
component of assembled MT in Noco/Tri cells (Fig. 3a).
MAPs are known to diVer in their abilities to stimulate
MT assembly; MAP2 promotes higher rates and higher
levels of MT assembly and nucleation than tau [34]. We
found that MAP2 predominated in assembled MT, with
Fig. 1 Microtubule assembly in 
Noco/Tri cells. 3T3 cells were 
extracted with 0.2% Triton X-
100 and used as a “cellular plat-
form” for MT assembly. a–c 
Microtubule network in intact 
3T3 cells. d–f detergent extract-
ed cells with or without pre-
treatment with Nocodazole. MT 
structure is faithfully preserved 
in detergent extracted 3T3 cells 
(d). Pretreatment with Nocodaz-
ole destroys endogenous MT (e) 
and its components are largely 
lost on detergent extraction (f). 
Rat brain cytosol, at various con-
centrations (5, 10, 15, 25 or 
50%) was added to Nocodazole 
pre-treated, detergent extracted 
3T3 cells (Noco/Tri cells) in the 
presence of 1 mM GTP to study 
MT assembly (g–k). Nocodaz-
ole inhibited MT assembly when 
added to the rat brain cytosol on 
Noco/Tri cells (l). Alpha tubulin 
(DM1A, green), tyrosinated 
tubulin (YL1/2, red). Scale bar 
represents 25 m123
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(Fig. 3b).
EVect of AD P-tau on MT assembly
To study the eVect of AD P-tau on MT network, we added
AD P-tau or as a control recombinant tau410 (100 g/ml
each) to rat brain cytosol and incubated Noco/Tri cells
with the reaction mixture for 1 h at 37°C in the presence of
phosphatase inhibitors (100 nM okadaic acid and 25 mM
sodium Xoride). No MTs assembled in the presence of AD
P-tau, and tau could be seen attached to the Noco/Tri cells
(Fig. 4a). Recombinant tau on the other hand, promoted the
bundling of MTs (Fig. 4a). These results suggest that AD
P-tau inhibits MT assembly in Noco/Tri cells and that
excess of normal tau (beyond that present in the 25% brain
cytosol) causes bundling of MT.
Next, we investigated the ability of AD P- tau to break-
down preassembled MTs in Noco/Tri cells (Fig. 4b). After
inducing MT assembly with rat brain cytosol for 20 min, rat
brain cytosol was replaced by an equal volume of either
warm PEM buVer containing 1 mM GTP alone (control), or
together with recombinant tau410 (100 g/ml), or AD P-tau
(100 g/ml), and incubated for 40 min. AD P-tau, caused
breakdown of MTs whereas recombinant tau promoted MT
bundling.
Binding of AD P-tau to normal MAPs in Noco/Tri cells
In order to investigate whether the breakdown of MT net-
work by AD P-tau induced its interaction with normal
MAPs, we immunostained Noco/Tri cells, which were
treated similar to Fig. 4a, with speciWc antibodies against
un-phosphorylated, normal tau (Tau-1) and AD P-tau (pSer
422). Control and recombinant tau410-treated Noco/Tri cells
showed robust staining of MT with Tau-1 indicating that
the majority of normal tau associated with MTs (compare
with Fig. 4a). AD P-tau-treated Noco/Tri cells displayed
Fig. 2 Time course of MT 
assembly/disassembly in Noco/
Tri cells. 3T3 cells were pre-
treated with 10 M nocodazole 
prior to detergent extraction. Rat 
brain cytosol (25%) was then ap-
plied to the Noco/Tri cells in the 
presence of GTP to study MT 
assembly at various time points 
(a). Microtubule organizing 
center (MTOC)-like structures 
could be detected as early as 
1 min after incubation with adult 
rat brain cytosol, whereas by 
10 min, MT growth from MTOC 
could be observed. Assembled 
MTs were stable for up to 4 h 
studied. b To study disassembly, 
MTs were Wrst assembled in 
Noco/Tri cells as described 
above for 20 min. The cells were 
then washed, incubated in PEM 
buVer, Wxed at diVerent time 
points, immunostained and ana-
lyzed by confocal microscopy. 
By 1 h, almost all MTs were dis-
assembled. Anti-alpha tubulin 
(DM1A) was used for immuno-
cytochemical staining. Scale bar 
represents 25 m123
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ing that AD P-tau had sequestered normal tau from the par-
ticipating pool of MAPs (Fig. 5a). Similarly, AD P-tau also
co-stained with MAP2 (Fig. 5b), indicating that it seques-
tered MAP2 from the system. Together, these results indi-
cate that AD P-tau causes breakdown of MT network by
sequestering normal tau and MAP2.
In order to Wnd out whether the eVect of AD P-tau on
MT dynamics was dependent on its concentration, we next
conWrmed the eVects of AD P-tau on MT assembly using
Western blots. MT assembly was studied in vitro by incu-
bating rat brain cytosol with varying concentrations (6.25–
100 g/ml) of recombinant tau410 or AD P-tau. After incu-
bation for 1 h, the sample was centrifuged and supernatant
and pellet were analyzed by Western blots to compare the
amount of tubulin in both fractions (Fig. 6). The proportion
of tubulin in the pellet reXected its assembly into MTs.
About 60% of tubulin assembled into MTs in 15% rat brain
cytosol. AD P-tau decreased the assembly of MTs in a
dose-dependent manner with concentrations of 50 g/ml
and above totally abolishing MT assembly. Tau410 by itself
had no signiWcant eVect on MT assembly.
Dephosphorylation of AD P-tau by PP-2A restores normal 
MT dynamics in Noco/Tri cells
Tau is a phospho protein and its biological activity is regu-
lated by the degree of phosphorylation [27]. Hyperphosph-
orylation alone is enough to confer tau with inhibitory
activities towards MT assembly. The activities of protein
kinases and phosphatases are therefore, critical to the regu-
lation of tau phosphorylation. We have previously shown
that AD P-tau can be dephosphorylated by protein phospha-
tases [17–19] and that this treatment restores its biological
activity in vitro [38]. Protein phosphatase 2A, which is
present in the brain and is relevant to AD pathology [28],
has the highest eYciency of restoring MT assembly-pro-
moting activity of AD P-tau in vitro [38]. We next studied
Fig. 3 Characterization of MTs 
assembled in Noco/Tri cells. 
MTs were assembled in Noco/
Tri cells using 25% rat brain ex-
tract. The cells were then stained 
for modiWed alpha tubulin and 
various MAPS. a Majority of 
assembled MTs had detyrosinat-
ed (Glu-tubulin) tubulin (-tubu-
lin, green; Glu-tubulin, red). 
Tyrosinated tubulin was largely 
absent from assembled MTs 
(Tyr-tubulin, red). b MAP2 was 
the major MAP in assembled 
MTs whereas tau co-localized 
considerably less with single 
MTs. MAP2 green, tau red. 
Scale bar represents 25 m123
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its inhibitory activity towards MT assembly in Noco/Tri
cells. For this purpose, we did two sets of experiments: in
the Wrst set of experiments, AD P-tau was treated with PP-
2A for 45 min at 37°C prior to its incubation with rat brain
cytosol for MT assembly in Noco/Tri cells. PP-2A releases
»50% of inorganic phosphate from AD P-tau within
45 min [38]. So the incubation mixture for MT assembly
contained partially dephosphorylated AD P-tau. Treatment
of AD P-tau with PP-2A partially restored its activity
towards MT assembly (Fig. 7a–c).
In the second set of experiments, AD P-tau was Wrst
added to the rat brain cytosol in order to inhibit MT assem-
bly in Noco/Tri cells (Fig. 7d). After 10 min, PP-2A was
added to the Noco/Tri cells and the samples were incubated
for another 20 min. PP-2A activity was then inhibited by
adding phosphatase inhibitors (100 nM Okadaic acid and
25 mM NaF) and the cells were further incubated for
20 min in the presence of fresh GTP and thereafter Wxed. A
twenty-minute treatment of AD P-tau by PP-2A releases
»30% phosphate per mole of AD P-tau [38]. There was
clear evidence of at least some MT “re-assembly” as seen
Fig. 4 EVect of AD P-tau on MT dynamics in Noco/Tri cells. MT
assembly was induced with 25% adult rat brain extract in Noco/Tri
cells in the presence or absence of 100 g/ml of either recombinant hu-
man brain tau410 or AD P-tau. a AD P-tau, but not tau410, completely
inhibited MT assembly. Tau410 promoted assembly and bundling of
MT. b MT were assembled on Noco/Tri cells for 20 min after which
rat brain cytosol was replaced with either warm PEM buVer containing
1 mM GTP alone (control), or 100 ml of tau410 or AD P-tau and incu-
bated for 40 min. AD P-tau, but not tau410, destroyed assembled MTs.
Scale bar represents 25 m. (-tubulin green, total tau red)
Fig. 5 Co-localization of AD P-tau with normal tau and MAP2 in
Noco/Tri cells. MT assembly was induced with 25% adult rat brain ex-
tract in Noco/Tri cells in the presence or absence of 100 g/ml of either
recombinant human brain tau410 or AD P-tau. AD P-tau sequestered
normal tau and MAP2 as seen by co-localization of AD P-tau (stained
with antibody to pSer 422, a site only phosphorylated in AD P-tau)
with normal, unphosphorylated tau (a) and MAP2 (b). Scale bar repre-
sents 25 m123
508 Acta Neuropathol (2007) 113:501–511by tubulin staining of the Noco/Tri cells (Fig. 7d–f). The
extent of MT assembly in this set of experiments was less
than that in the Wrst set of experiments probably because of
a relatively less dephosphorylation of AD P-tau.
Western blot analysis of AD P-tau pretreated with PP-
2A for 45 min at 37°C, showed its dephosphorylation at
multiple phosphorylation sites, as evident by immunostain-
ing with Tau-1, PHF-1, M4 and 12E8 phospho-dependent
tau antibodies (Fig. 7g).
These results indicate that AD P-tau competes with nor-
mal tau to inhibit MT assembly and that PP-2A-induced
dephosphorylation of AD P-tau restores it to a normal-like
protein.
Discussion
Dysregulation of MT dynamics leads to retrograde degen-
eration of neurons in Alzheimer disease and related tauopa-
thies. With a disrupted MT network, many subcellular
processes, which are vital for neuronal physiology are shut
down, synapses are lost and the aVected neurons die. One
of the key elements in retrograde degeneration of Alzhei-
mer type is the hyperphosphorylation of tau. Observations
from in vitro studies suggest that hyperphosphorylated tau
is inhibitory to MT assembly and stability. However, the
precise mechanism by which hyperphosphorylated tau
aVects MT dynamics in the cell has been diYcult to study.
This is due to limitations in carrying out such studies with-
out disturbing other cellular processes. In this study, we
have employed a model in which we have replaced the
cytoplasm of mouse embryonic Wbroblasts with adult rat
brain cytosol, creating a mature neuron-like environment of
MT network made up of mostly Glu-tubulin, MAP2 and
tau. Using this model, we show that AD P-tau causes a
breakdown of the MT network by sequestering normal tau
and MAP2, and that this inhibitory activity of AD P-tau can
be reversed by its dephosphorylation by PP-2A.
Detergent extraction of cells with a non-ionic detergent
like Triton X-100 removes all “soluble components” of the
cytoplasmic ground substance. What remain are the ele-
ments of the cytoskeleton and the nuclear remnant. When
intact cells are treated with Nocodazole to disassemble
existing MT network, free tubulin is extracted along with
the cytoplasmic ground substance. The remaining detergent
extracted cells can now be employed as a “cellular plat-
form” to create diVerent cellular environments. By replac-
ing cytosolic ground substance of the host cells with adult
rat brain cytosol, a neuron-like environment is created in
which the assembled MT not only structurally resemble
neuronal MT (being enriched in Glu-tubulin) but also faith-
fully recapitulate the dynamics of MT in intact neurons.
Apart from acting as a source neuronal tubulin, 25% rat
brain cytosol also provides the necessary MAPs to promote
Fig. 6 Concentration-dependent eVect of AD P-tau on MT assembly
from rat brain cytosol. Fifteen percent rat brain cytosol containing
1 mM GTP was used as a source of tubulin and MAPs for MT assem-
bly. Recombinant tau410 or AD P-tau was added at diVerent concentra-
tions (6.25–100 g/ml) and incubated for 1 h at 37°C. Pellets and
supernatants were separated by centrifugation at 5,600g. a After dis-
solving pellets in 0.4% SDS, both supernatants and pellets were ana-
lyzed with anti-tubulin (DM1A) by Western blots. b Quantitations
were done by scanning chemiluminiscent (ECL) Western blots. AD P-
tau decreased MT assembly in a dose dependent manner, whereas
tau410 had no signiWcant eVect. Data in b represent mean § SEM.
* P < 0.05, ** P < 0.01, *** P < 0.001123
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seen as early as 1 min after incubation in the rat brain cyto-
sol and the MT network so formed is stable for upto 4 h.
When rat brain cytosol is replaced by buVer, all MTs disas-
semble within 1 h. Immunostaining of Noco/Tri cells
shows that the assembled MTs closely resemble neuronal
MT network. They are enriched in Glu-tubulin, which is
found in stable assemblies of MT in diVerentiated cells.
Although both MAP2 and tau co-stain with the MT net-
work, MAP2 is the predominant MAP owing to its greater
ability in promoting MT assembly [34]. When the reaction
is carried out in the presence of AD P-tau, no MTs are seen,
suggesting that AD P-tau inhibits MT assembly. Moreover,
when AD P-tau is added to preassembled MT, all MT are
destroyed. The eVect of AD P-tau on MT assembly is dose
dependant, with concentrations of 50 g/ml and above
totally abolishing MT assembly. Normal tau in the brain
cytosol, on the other hand, promotes MT assembly and
additional unphosphorylated tau causes bundling of MTs.
AD P-tau causes inhibition of MT assembly by sequester-
ing normal tau and MAP2, as shown by co-staining of
pSer422 immunoreactive tau (an epitope of AD P-tau) with
Tau-1 immunoreactive tau (an epitope of normal tau), and
with MAP2. When a protein phosphatase like PP-2A is
introduced in the system, AD P-tau gets dephosphorylated
and is now available for MT assembly. This is evidenced
by observing MT “re-assembly” in the AD P-tau-treated
Noco/Tri cells in which PP-2A has been added.
Fig. 7 EVect of dephosphorylation of AD P-tau on MT dynamics in
Noco/Tri cells. AD P-tau was either treated with PP-2A prior to incu-
bation for MT assembly (b, c) or during the incubation (d–f). In b, c
AD P-tau (50 g/ml) was treated with PP-2A (1 U/ml) for 45 min at
37°C prior to its incubation with 25% rat brain cytosol for MT assem-
bly in Noco/Tri cells; cells treated with the brain cytosol in the absence
of AD P-tau were used as a control. Dephosphorylation of AD P-tau
with PP-2A partially restored its activity to promote MT assembly
(compare c with b). In d–f, 25% rat brain extract was incubated with
AD P tau (50 g/ml) on Noco/Tri cells for 10 min to inhibit MT assem-
bly (d). PP-2A was then added to the incubation mixture for 20 min be-
fore phosphatase inhibitors to inhibit PP-2A activity (f). Fresh GTP
was supplied at this time and the cells were Wxed after another 20 min
incubation and stained with -tubulin antibody. MT partially “re-
assembled” in PP-2A treated Noco/Tri cells (f). PP-2A-catalyzed
dephosphorylation of AD P-tau was conWrmed by Western blot (g).
AD P-tau (50 g/ml) was treated with PP-2A (1 U/ml) for 45 min at
37°C and subjected to Western blot analysis. A decrease in tau phos-
phorylation at Tau-1, PHF-1, M4 and 12E8 epitopes is evident. Stan-
dard bar represents 25 m123
510 Acta Neuropathol (2007) 113:501–511In summary, AD P-tau inhibits MT assembly by a pro-
cess, which involves sequestration of normal MAPs,
including MAP2 and tau. This inhibitory activity is revers-
ible, as MT re-assemble when normal tau becomes avail-
able following dephosphorylation of AD P-tau with PP-2A.
Since tau is the major MAP associated with axonal MT
whereas MAP2 is localized mainly in the dendritic pool of
MT, removal of participating MAPs (tau and MAP2) from
dynamic assemblies of MT forms, the basis of retrograde
degeneration of both dendrites and axons seen in AD and
related tauopathies. The Noco/Tri cells employed in this
study provide a simple and relevant platform to study the
neuronal cytoskeleton in a neuron-like environment. As a
further extension, this model can be used to develop rapid
screening assays for compounds with the potential to pre-
vent or reverse neuroWbrillary degeneration.
Acknowledgments We are grateful to Dr. Lester Binder, Northwest-
ern University Medical School, Chicago, IL, USA for Tau-1 antibody;
Dr. Peter Davies, Albert Einstein College of Medicine, Bronx, NY, for
PHF-1 antibody; Dr. Dale Schenk, Elan Pharmaceuticals, San Fran-
cisco, CA, for 12E8 antibody; Dr. Yasuo Ihara, University of Tokyo,
Tokyo, Japan, for M4 antibody; and Dr. A del C. Alonso, NYS Institute
for Basic Research, Staten Island, NY, USA for anti-Glu-tubulin anti-
body. Janet Murphy provided secretarial assistance. Studies in our lab-
oratories were supported in part by the New York State OYce of
Mental Retardation and Developmental Disabilities and NIH grant
AG019158.
References
1. Alonso AC, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of
abnormally phosphorylated tau in the breakdown of microtubules
in Alzheimer disease. Proc Natl Acad Sci USA 91:5562–5566
2. Alonso AC, Grundke-Iqbal I, Iqbal K (1996) Alzheimer’s disease
hyperphosphorylated tau sequesters normal tau into tangles of
Wlaments and disassembles microtubules. Nat Med 2:783–787
3. Alonso AC, Grundke-Iqbal I, Barra HS, Iqbal K (1997) Abnormal
phosphorylation of tau and the mechanism of Alzheimer neuroW-
brillary degeneration: sequestration of microtubule-associated proteins
1 and 2 and the disassembly of microtubules by the abnormal tau.
Proc Natl Acad Sci USA 94:298–303
4. Alonso AC, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001)
Hyperphosphorylation induces self-assembly of tau into tangles of
paired helical Wlaments/straight Wlaments. Proc Natl Acad Sci
USA 98:6923–6928
5. Alonso AC, Li B, Grundke-Iqbal I, Iqbal K (2006) Polymerization
of hyperphosphorylated tau into Wlaments eliminates its inhibitory
activity. Proc Natl Acad Sci USA 103:8864–8869
6. Benitez-King G, Tunez I, Bellon A, Ortiz GG, Anton-Tay F
(2003) Melatonin prevents cytoskeletal alterations and oxidative
stress induced by okadaic acid in N1E-115 cells. Exp Neurol
182:151–159
7. Brown S, Levinson W, Spudich JA (1976) Cytoskeletal elements
of chick embryo Wbroblasts revealed by detergent extraction.
J Supramol Struct 5:119–130
8. Bulinski JC, Gundersen GG (1991) Stabilization of post-transla-
tional modiWcation of microtubules during cellular morphogene-
sis. Bioessays 13:285–293
9. Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X,
Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa
M, Avila J, Jones PK, Castellani RJ, Smith MA, Perry G (2003)
Microtubule reduction in Alzheimer’s disease and aging is inde-
pendent of tau Wlament formation. Am J Pathol 162:1623–1627
10. Chen LQ, Wei JS, Lei ZN, Zhang LM, Liu Y, Sun FY (2005)
Induction of Bcl-2 and Bax was related to hyperphosphorylation of
tau and neuronal death induced by okadaic acid in rat brain. Anat
Rec A Discov Mol Cell Evol Biol 287:1236–1245
11. Chohan MO, Haque N, Alonso AC, El-Akkad E, Grundke-Iqbal I,
Grover A, Iqbal K (2005) Hyperphosphorylation-induced self
assembly of murine tau: a comparison with human tau. J Neural
Transm 112:1035–1047
12. Chohan MO, Khatoon S, Grundke-Iqbal I, Iqbal K (2006) Involve-
ment of I2PP2A in the abnormal hyperphosphorylation of tau and
its reversal by Memantine. FEBS Lett 580:3973–3979
13. Churcher I (2006) Tau therapeutic strategies for the treatment of
Alzheimer’s disease. Curr Top Med Chem 6:579–595
14. Dodart JC, Mathis C, Bales KR, Paul SM (2002) Does my mouse
have Alzheimer’s disease? Genes Brain Behav 1:142–155
15. Fath T, Eidenmuller J, Brandt R (2002) Tau-mediated cytotoxicity
in a pseudohyperphosphorylation model of Alzheimer’s disease.
J Neurosci 22:9733–9741
16. Gilbert M, Fulton AB (1985) The speciWcity and stability of the tri-
ton-extracted cytoskeletal framework of gerbil Wbroma cells.
J Cell Sci 73:335–345
17. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K (1994) Alzheimer’s
disease abnormally phosphorylated tau is dephosphorylated by
protein phosphatase-2B (calcineurin). J Neurochem 62:803–806
18. Gong CX, Grundke-Iqbal I, Damuni Z, Iqbal K (1994) Dephos-
phorylation of microtubule-associated protein tau by protein phos-
phatase-1 and -2C and its implication in Alzheimer disease. FEBS
Lett 341:94–98
19. Gong CX, Grundke-Iqbal I, Iqbal K (1994) Dephosphorylation of
Alzheimer’s disease abnormally phosphorylated tau by protein
phosphatase-2A. Neuroscience 61:765–772
20. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS,
Wisniewski HM (1986) Microtubule-associated protein tau.
A component of Alzheimer paired helical Wlaments. J Biol Chem
261:6084–6089
21. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM,
Binder LI (1986) Abnormal phosphorylation of the microtubule-
associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Proc Natl Acad Sci USA 83:4913–4917
22. Gundersen GG, Bulinski JC (1986) Microtubule arrays in diVeren-
tiated cells contain elevated levels of a post-translationally modi-
Wed form of tubulin. Eur J Cell Biol 42:288–294
23. Hong HN, Yoon SY, Suh J, Lee JH, Kim D (2002) DiVerential
activation of caspase-3 at two maturational stages during okadaic
acid-induced rat neuronal death. Neurosci Lett 334:63–67
24. Iqbal K, Alonso AC, Chen S, Chohan MO, El-Akkad E, Gong CX,
Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal
I (2005) Tau pathology in Alzheimer disease and other tauopa-
thies. Biochim Biophys Acta 1739:198–210
25. Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaikh
SS, Wisniewski HM, AlafuzoV I, Winblad B (1986) Defective
brain microtubule assembly in Alzheimer’s disease. Lancet
23:421–426
26. Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal
I (1993) Microtubule-associated protein tau: Abnormal phosphor-
ylation of a non-paired helical Wlament pool in Alzheimer disease.
J Biol Chem 268:24374–24384
27. Lindwall G, Cole RD (1984) Phosphorylation aVects the ability of
tau protein to promote microtubule assembly. J Biol Chem
259:5301–5305123
Acta Neuropathol (2007) 113:501–511 51128. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of
protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation
of tau phosphorylation. Eur J Neurosci 22:1942–1950
29. McNaught KS, Olanow CW (2006) Protein aggregation in the
pathogenesis of familial and sporadic Parkinson’s disease. Neuro-
biol Aging 27:530–545
30. Mesland DA, Spiele H (1984) Brief extraction with detergent
induces the appearance of many plasma membrane-associated
microtubules in hepatocytic cells. J Cell Sci 68:113–137
31. Montejo de Garcini E, Carrascosa JL, Correas I, Nieto A, Avila J
(1988) Tau factor polymers are similar to paired helical Wlaments
of Alzheimer’s disease. FEBS Lett 236:150–154
32. Oyama F, Shimada H, Oyama R, Titani K, Ihara Y (1993) Beta-
amyloid protein precursor and tau mRNA levels versus beta-amy-
loid plaque and neuroWbrillary tangles in the aged human brain.
J Neurochem 60:1658–1664
33. Redeker V, Rossier J, Frankfurter A (1998) Posttranslational mod-
iWcations of the C-terminus of alpha-tubulin in adult rat brain:
alpha 4 is glutamylated at two residues. Biochemistry 37:14838–
14844
34. Sandoval IV, Vandekerckhove JS (1981) A comparative study of
the in vitro polymerization of tubulin in the presence of the micro-
tubule-associated proteins MAP2 and tau. J Biol Chem 256:8795–
8800
35. Schliwa M, van Blerkom J, Porter KR (1981) Stabilization and the
cytoplasmic ground substance in detergent-opened cells and a
structural and biochemical analysis of its composition. Proc Natl
Acad Sci USA 78:4329–4333
36. Singh TJ, Haque N, Grundke-Iqbal I, Iqbal K (1995) Rapid
Alzheimer-like phosphorylation of tau by the synergistic actions
of non-proline-dependent protein kinases and GSK-3. FEBS Lett
358:267–272
37. Sloboda RD, Rudolph SA, Rosenbaum JL, Greengard P (1975)
Cyclic AMP-dependent endogenous phosphorylation of a micro-
tubule-associated protein. Proc Natl Acad Sci USA 72:177–181
38. Wang JZ, Grundke-Iqbal I, Iqbal K (1996) Restoration of biologi-
cal activity of Alzheimer abnormally phosphorylated tau by
dephosphorylation with protein phosphatase-2A, -2B and -1. Brain
Res Mol Brain Res 38:200–208
39. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975)
Protein factor essential for microtubule assembly. Proc Natl Acad
Sci USA 72:1858–1862
40. Yoon S, Choi J, Yoon J, Huh JW, Kim D (2006) Okadaic acid
induces JNK activation, bim overexpression and mitochondrial
dysfunction in cultured rat cortical neurons. Neurosci Lett
394:190–195123
